Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ahmet Demirel
Observed names:
Ahmet DEMİREL,
Ahmet Demi̇rel
Institutions:
Marmara Üniversitesi Eğitim ve Araştırma Hastanesi,
Marmara University
Observed institutions:
Marmara Üniversitesi Eğitim ve Araştırma Hastanesi,
Marmara University
ORCID:
0000-0001-8162-8294
Observed ORCID:
0000-0001-8162-8294
OpenAlex ID:
A5123961592
Immune checkpoint inhibitors and myocarditis–myositis–myasthenia gravis overlap: a FAERS pharmacovigilance study with time-to-onset characterization
2026
·
Burak Pacaci
, Bilal Yildirim
, et al.
·
Frontiers in Pharmacology
·
3
PDF
Acquired CD74–ROS1 fusion–mediated osimertinib resistance successfully treated with osimertinib and crizotinib: a case report
2026
·
Ali Kaan Güren
, Erkam Kocaaslan
, et al.
·
Journal of Chemotherapy
·
2
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma
2026
·
Burak Paçacı
, Erkam Kocaaslan
, et al.
·
Journal of Clinical Medicine
·
2
PDF
Digital health engagement and health literacy among cancer patients: a cross-sectional study of ICT usage patterns
2026
·
Abdussamet Çelebi
, Nur Aybüke Bircan
, et al.
·
BMC Health Services Research
·
1
Capecitabine-induced pneumonitis: a rare case report and literature review
2026
·
Mustafa A. Tunç
, Ali K. Güren
, et al.
·
Anti-Cancer Drugs
·
1
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab
2026
·
Erkam Kocaaslan
, Ali Kaan Güren
, et al.
·
Journal of Clinical Medicine
·
1
PDF
Real-world plasma-based next-generation sequencing findings in metastatic lung adenocarcinoma: a single-center retrospective study
2026
·
Erkam Kocaaslan
, Emir Göçer
, et al.
·
Marmara medical journal
PDF
Prognostic Value of a Seven-Factor Risk Stratification System in T3N0 Colon Cancer: A Single-Center Retrospective Study
2026
·
Abdussamet Çelebi
, Eren Meral
, et al.
·
Medicina
Baseline and Early On-Treatment Prognostic Nutritional Index in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors
2026
·
Ezgi Çoban
, Atilla Eren Kurt
, et al.
·
Journal of Clinical Medicine
Stage-Specific Prognostic Impact of Longitudinal Body Composition Changes in Patients with Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX: A Dual-Cohort Study
2026
·
Ahmet Demirel
, Bora İnceöz
, et al.
·
Journal of Clinical Medicine
Prognostic Significance of Postoperative Edema in Surgically Treated Non-glioblastoma Diffuse Glioma
2026
·
Erkam KOCAASLAN
, Gülşah ÖZDEN
, et al.
·
Journal of Oncological Sciences
PDF
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies
2026
·
Mustafa Alperen Tunç
, Ali Kaan Güren
, et al.
·
Journal of Clinical Medicine
PDF
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature
2026
·
Cevat İlteriş Kıkılı
, Murat Araz
, et al.
·
Clinical Genitourinary Cancer
Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH score
2026
·
Burak Pacaci
, Buket Erkan Ozmarasali
, et al.
·
BMC Cancer
Comparative overall survival in T4N0 and T2-3N1 non-metastatic colon cancer: a retrospective cohort study
2026
·
Fırat Akagunduz
, Ali Kaan Güren
, et al.
·
Annals of Saudi Medicine
Oncological Perspective on Bone-Metastatic Colorectal Cancer: a Single-Centre Experience
2026
·
Ahmet Demi̇rel
, Ali Kaan Guren
, et al.
·
Journal of Gastrointestinal Cancer
Show more works
View as search
Works count:
16
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type